Search Results - "Springfeld, C."

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Authors: Uzunoglu FG Springfeld C Peccerella T et al.

Source: Hepatobiliary surgery and nutrition [Hepatobiliary Surg Nutr] 2026 Feb 01; Vol. 15 (1), pp. 15. Date of Electronic Publication: 2026 Jan 19.

Publication Type: Editorial; Comment

Journal Info: Publisher: AME Publishing Company Country of Publication: China (Republic : 1949- ) NLM ID: 101600750 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2304-3881 (Print) Linking ISSN: 23043881 NLM ISO Abbreviation: Hepatobiliary Surg Nutr Subsets: PubMed not MEDLINE

ASO Author Reflections: Looking Beyond Imaging-Multimodal Response Assessment after Modern Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma.

Authors: McClelland PH Ahmad SA

Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

ASO Author Reflections: What is the Role of Time Interval Between Preoperative Chemotherapy and Surgery in Locally Advanced Pancreatic Cancer?

Authors: Cathomas M Loos M

Source: Annals of surgical oncology [Ann Surg Oncol] 2026 Jun; Vol. 33 (6), pp. 5104-5105. Date of Electronic Publication: 2026 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.

Authors: Walle T Bajaj S Kraske JA et al.

Corporate Authors: Walle T Bajaj S Kraske JA et al.

Source: Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1137.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE

ASO Author Reflections: Complete Pathological Response after Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinomas-Curative Surgery in Cured Patients?

Authors: Addeo P Muzzolini M Laurent C et al.

Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Apr; Vol. 32 (4), pp. 2861-2863. Date of Electronic Publication: 2025 Feb 01.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE; In Process

Real-World Outcomes of Ivosidenib in IDH1-Mutant Biliary Tract Cancer: A Multicenter Retrospective Analysis and Comparison with the TrinetX Database.

Authors: Dreikhausen L Olkus A Dill M et al.

Source: Targeted oncology [Target Oncol] 2026 May; Vol. 21 (3), pp. 411-420. Date of Electronic Publication: 2026 Apr 20.

Publication Type: Journal Article; Multicenter Study; Comparative Study

Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

Macrophage Polarization as a Target for Colorectal Cancer Treatment Optimization: A Systematic Review.

Authors: Seraphine, Caden Macleod, Anne Thornsberry, Tristan et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2049. 27p.

ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?

Authors: Miller PN Nakakura EK

Source: Annals of surgical oncology [Ann Surg Oncol] 2024 Sep; Vol. 31 (9), pp. 6203-6204. Date of Electronic Publication: 2024 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

Post-Surgical Remodeling of Circulating Monocytes Identifies CD86 Expression on Non-Classical Monocytes as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.

Authors: Arnold, Lisa-Sophie Jacobsen, Anne Kuchenreuther, Isabelle et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p5012. 15p.

Minimally Invasive Versus Open Pancreaticoduodenectomy for Distal Cholangiocarcinoma: An Updated Disease-Specific Systematic Review and Meta-Analysis.

Authors: Li, Yi Lei, Yulin Yang, Wenli et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1328. 16p.

Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol.

Authors: Stoop, T. F. Seelen, L. W. F. van 't Land, F. R. et al.

Source: BMC Cancer. 2/19/2025, Vol. 25 Issue 1, p1-12. 12p.

Longitudinal CE-MRI-based Siamese network with machine learning to predict tumor response in HCC after DEB-TACE.

Authors: Wei N Mathy RM Chang DH et al.

Source: Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2025 Aug 19; Vol. 25 (1), pp. 104. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101172931 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-7330 (Electronic) Linking ISSN: 14707330 NLM ISO Abbreviation: Cancer Imaging Subsets: MEDLINE

OCIAD2 as a novel prognostic and therapeutic biomarker for pancreatic cancer: A study based on transcriptomic signature and bioinformatics analysis.

Authors: Cui, Zhongyuan Lei, Xia Gou, Yani et al.

Source: PLoS Computational Biology. 10/7/2025, Vol. 21 Issue 10, p1-19. 19p.

Safety and pathological impact of resection after high-dose PBT for locally advanced pancreatic cancer.

Authors: Shimomura, Osamu Numajiri, Haruko Hashimoto, Shinji et al.

Source: World Journal of Surgical Oncology. 10/1/2025, Vol. 23 Issue 1, p1-10. 10p.

De novo induction of tertiary lymphoid structures: an immunotherapeutic strategy in pancreatic cancer.

Authors: Ahmed A Springfeld C Halama N

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2025 May 26; Vol. 10 (1), pp. 173. Date of Electronic Publication: 2025 May 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE; In Process

New implications from long-term outcomes of perioperative therapy in resectable pancreatic cancer.

Authors: Springfeld C Hackert T Palmer DH et al.

Source: British journal of cancer [Br J Cancer] 2026 Feb; Vol. 134 (4), pp. 531-542. Date of Electronic Publication: 2025 Dec 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

CCR5+ CD8+ T Cells Are Associated with Poor Response to PD-1 Blockade Therapy.

Authors: Zhao, Ziheng Liu, Yuwei Wu, Zhaofei et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4963. 21p.

Targeting Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma: Rationale, Current Evidence, and a CEACAM6 CAR-T Strategy.

Authors: Piejko, Marcin Bak, Karolina Wierciak, Joanna et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1852. 20p.

The Gut–Liver Axis in HCC Immunotherapy.

Authors: Taliente, Francesco De Rose, Agostino Maria Maresca, Paolo et al.

Source: Gastroenterology Insights. Jun2026, Vol. 17 Issue 2, p34. 14p.

Multiphasic Evidential Decision-Making Matrix (MedMax) for Intrahepatic Cholangiocarcinoma: A Single-Center Validation Study.

Authors: Ramouz, Ali Adeliansedehi, Ali Chagervand, Behboud Moeini et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1365. 12p.